Holt, MI – Orchid Orthopedic Solutions (Orchid), a global leader in the design and manufacture of orthopedic implants, announced that Matt Tharp joined the company as Chief Financial Officer (CFO) on April 5, 2021.
Matt comes to Orchid from Ammega, where he held the role of CFO – Americas. He has 20+ years of experience in supply chain, operations and finance. Matt has held leadership roles in both private equity and public companies. Additionally, Matt has been the CFO at three other companies. He has a reputation of delivering operational financial excellence and leading mergers and acquisitions. Before Ammega, Matt held various roles at Midwest Industrial Rubber, Presence From Innovation, HD Supply, and Anheuser-Busch.
“Our mission is to be the premier provider of orthopedic implant solutions and the preferred destination for talent in our industry. We know that having strong financial performance helps drive growth. To continue building on our mission, I am pleased to announce the addition of Matt Tharp to the Orchid Leadership Team,” said Nate Folkert, Orchid’s Chief Executive Officer.
About Orchid Orthopedic Solutions
Orchid is a world leader in orthopedic medical device solutions, providing design and manufacturing services globally. As a strategic partner, Orchid has the capability of providing entire implant procedure and product design services, as well as, complete single source manufacturing. Orchid has the broadest portfolio in the industry, ranging from design and development through finished goods manufacturing and packaging, improving customers’ supply chains and adhering to the highest quality standards in the industry. Orchid specializes in implants, single use instruments and innovative technologies within joint reconstruction, hips, knees, spine, trauma, extremities and dental. For further information, please see www.orchid-ortho.com.